Merck (Mexico) Insiders
| MRK Stock | MXN 2,015 21.44 1.05% |
Merck employs about 44 people. The company is managed by 10 executives with a total tenure of roughly 32 years, averaging almost 3.0 years of service per executive, having 4.4 employees per reported executive. Break down of Merck's management performance can provide insight into the company performance.
| Kenneth Frazier Chairman Chairman, CEO and Pres |
| Robert JD Chairman Pres Chairman |
Merck |
Merck Management Team Effectiveness
The company has return on total asset (ROA) of 0.1268 % which means that it generated a profit of $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.351 %, meaning that it generated $0.351 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.Merck Workforce Comparison
Merck Company is regarded fifth in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is now estimated at about 138,552. Merck adds roughly 44.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of 0.24 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.38 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.38. Merck Company Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck Company Price Series Summation is a cross summation of Merck price series and its benchmark/peer.
Merck Notable Stakeholders
A Merck stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck often face trade-offs trying to please all of them. Merck's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kenneth Frazier | Chairman, CEO and Pres | Profile | |
| Robert JD | Pres Chairman | Profile | |
| Richard DeLuca | Executive Vice President and Presidentident - Merck Animal Health | Profile | |
| Cristal Downing | Ex Officer | Profile | |
| Jennifer Zachary | General Counsel | Profile | |
| David Williams | Ex Officer | Profile | |
| Caroline Litchfield | Ex CFO | Profile | |
| Lisa LeCointeCephas | VP Officer | Profile | |
| Peter Dannenbaum | VP Relations | Profile | |
| Jennifer Mauer | VP Communications | Profile |
About Merck Management Performance
The success or failure of an entity such as Merck Company often depends on how effective the management is. Merck management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 69000 people.
Please note, the imprecision that can be found in Merck's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck Company. Check Merck's Beneish M Score to see the likelihood of Merck's management manipulating its earnings.
Merck Workforce Analysis
Traditionally, organizations such as Merck use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck within its industry.Merck Manpower Efficiency
Return on Merck Manpower
| Revenue Per Employee | 1.3B | |
| Revenue Per Executive | 5.9B | |
| Net Income Per Employee | 330M | |
| Net Income Per Executive | 1.5B |
Additional Tools for Merck Stock Analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.